U.S. Government Shutdown Freezes Billions in Deals as Businesses Wait on Washington

U.S. Government Shutdown Freezes Billions in Deals as Businesses Wait on Washington

The federal shutdown is stalling IPOs, mergers, and drug approvals as agencies like the SEC and FDA grind to a halt. Companies across biotech, energy, and finance face costly delays with billions in growth trapped in limbo.